Dublin, June 26, 2019 (GLOBE NEWSWIRE) -- The "Female Contraception: United States Market Outlook to 2024" report has been added to ResearchAndMarkets.com's offering.
This latest research provides comprehensive insights into Female Contraception pipeline products, Female Contraception epidemiology, Female Contraception market valuations and forecast, Female Contraception drugs sales and competitive landscape in the US.
The research is classified into seven sections - Female Contraception treatment options, pipeline products, market analysis comprising of epidemiology, key products marketed, market valuations and forecast, drugs sales and market shares.
Research Scope
Benefits of this Research
Key Topics Covered
1) Female Contraception Treatments
2) Female Contraception Pipeline
3) US Female Contraception Epidemiology
4) Marketed Drugs for Female Contraception in US
5) US Female Contraception Market Size and Forecast
6) US Female Contraception Products Sales and Forecast
7) US Female Contraception Market Competitive Landscape
8) Methodology
List of Tables
1. Female Contraception Phase 3 Clinical Trials, 2019
2. Female Contraception Phase 2 Clinical Trials, 2019
3. Female Contraception Phase 1 Clinical Trials, 2019
4. Female Contraception Epidemiology, US, 2014 - 2024
5. Marketed Drugs for Female Contraception, US, 2018
6. Female Contraception Market Size and Forecast ($), US, 2014 - 2024
7. Female Contraception Product Sales ($), US, 2014 - 2024
List of Figures
1. Female Contraception Epidemiology, US, 2014 - 2024
2. Female Contraception Market Size and Forecast ($), US, 2014 - 2024
3. Female Contraception Products Market Share (%), US, 2018
For more information about this report visit https://www.researchandmarkets.com/r/hyprbg
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 Related Topics: Women's Health